Nuvisan

Nuvisan

Arzneimittelherstellung

Wir wissen, wie man Medikamente der nächsten Generation entdeckt, entwickelt und auf den Markt bringt!

Info

Die NUVISAN-Gruppe ist eine Contract Research Organization (CRO) und Contract Manufacturing Organization (CDMO) mit Hauptsitz in Neu-Ulm und sechs Standorten in Deutschland und Frankreich (Neu-Ulm, Berlin, Grafing, Gauting, Waltrop und Sophia-Antipolis) sowie Monitoring-Aktivitäten mit Niederlassungen in Argentinien, Peru und Brasilien sowie in den USA. NUVISAN bietet integrierte und gekoppelte Dienstleistungen und Lösungen entlang der Wertschöpfungskette der Arzneimittelentwicklung von der Identifizierung des Ziels bis zum Patienten mit allen unterstützenden Dienstleistungen (DMPK, GMP-Synthese, Formulierungsentwicklung und -analyse, Bioanalyse, Phase-1-CPU, Versorgung mit klinischen Studien und Überwachung). Eine nachgewiesene Erfolgsbilanz von über 40 Jahren kontinuierlichem Service ist ein Beweis für die operative Exzellenz und die Erfahrung unserer 1.000 hochqualifizierten Mitarbeiter.

Website
http://www.nuvisan.com
Branche
Arzneimittelherstellung
Größe
501–1.000 Beschäftigte
Hauptsitz
Neu-Ulm
Art
Privatunternehmen
Gegründet
1989
Spezialgebiete
Target Identification, 2D/3D Modeling, Bioinformatics, Compound Libraries, High-Throughput Screening, Pharmacology, Structural Biology, Fragment-Based Drug Design, Computational Chemistry, Hit-to-Lead Optimization, In vitro & In vivo DMPK, API Manufacturing, Radiosynthesis/Isotope Labeling, Small & Large Molecule Bioanalysis, Immunogenicity Testing, Biomarker Analysis & Discovery, QP Services, In-house Clinical Pharmacology Unit, Clinical & Medical Monitoring, Clinical Development, Chemistry und R&D Innovation

Orte

Beschäftigte von Nuvisan

Updates

  • Unternehmensseite von Nuvisan anzeigen, Grafik

    14.663 Follower:innen

    🚀 It’s a wrap for NUVISAN's Our Science series! As our Science Series comes to a close after a wonderful couple of months, we want to take a moment to reflect on the journey we've shared. Throughout this series, we have delved into various fascinating topics and explored groundbreaking discoveries. We hope that each post has sparked your curiosity, and perhaps even inspired a deeper interest in the sciences. It has been our pleasure to bring you engaging content and insightful discussions. While our Science Series may be concluding, our commitment to delivering informative and captivating content continues. Stay tuned for more exciting topics and updates! 🤝 💫 🚀 Impurity Profiling: https://lnkd.in/eDysdwsm 💻 Bioinformatic Analysis: https://lnkd.in/eJwH6sHA 🚀 Single Cell RNA-sequencing: https://lnkd.in/ewkhnCmT 🌈 Spectral Flow Cytometry: https://lnkd.in/efwMvFr8 🎯 Targeted Protein Degradation (TPD): https://lnkd.in/eb-e-pYF 🚀 Organoids as a new tool for drug screening: https://lnkd.in/eVygivqK 🎨  Cell Painting: https://lnkd.in/esWNMirX 📯 NUVISAN's Game-Changing Compound Libraries: https://lnkd.in/etMX6Uhr 🚀 Developmental Metabolite Identification - Part II: https://lnkd.in/eAi6hEkn 💊 eSource Data Collection in Clinical Trials: https://lnkd.in/ewa9pKfZ 💊 Developmental Metabolite Identification - Part I: https://lnkd.in/exkZ7UHB 🔬 Revolutionizing Therapeutics with LNPs: https://lnkd.in/ec2hNyeJ 🔬 In vitro drug release test (IVRT) solutions: https://lnkd.in/emuzjD8z 🚀 Pinpoint your drug candidate´s CYP450 induction potential: https://lnkd.in/ehEB2y_y 🚀 Cryo-Electron Microscopy(Cryo-EM): https://lnkd.in/ewGvngEJ #OurScience #NUVISAN #theScienceCRO #drugdiscovery #drugdevelopment

  • Unternehmensseite von Nuvisan anzeigen, Grafik

    14.663 Follower:innen

    We are delighted to be engaging with numerous globally renowned research institutions and pharmaceutical companies in the impactful and exciting CARE Consortium projects. 📯 We are thrilled to share insights into CARE Consortium Work Package 3, which focuses on antiviral drug development from hits to leads. #covid19 #CAREvsCOVID #careconsortium #NUVISAN #drugdiscovery

  • Unternehmensseite von Nuvisan anzeigen, Grafik

    14.663 Follower:innen

    📢 We are at ISSCR 2024! We are excited to be part of the most comprehensive gathering in stem cell research—ISSCR 2024 from today until Saturday. Our colleagues Norman Liaw, Claudia Noack, Skadi Lau, Maike Marczenke, and Krzysztof Brzezinka look forward to connecting with you to introduce our NUVISAN iPSC platform and explore potential collaborations. 🤝 Stop by our booth (#502) and chat with us! 📅 Also, don’t forget to join Norman’s talk at the Exhibit Hall Theater H on July 12, from 16:20 to 16:35. #ISSCR2024 #ipscs #stemcell #diseasemodeling #compoundscreening

    • Kein Alt-Text für dieses Bild vorhanden
  • Unternehmensseite von Nuvisan anzeigen, Grafik

    14.663 Follower:innen

    We Cycle for a better Climate! 🚴♂️ We are delighted to have more colleagues involved in CITY CYCLING this year! By participating in this initiative, we're enhancing our health and well-being, reducing carbon emissions, and contributing to cleaner, greener cities. Together, we're fostering a healthier lifestyle for ourselves and a healthier planet for future generations. Our highlights: 🌱 20,820 kilometers covered: Together, we covered an impressive distance, saving 3,456.2 kilograms of CO2 as a result! 💪 Team spirit and health: Our participation not only improved our fitness but also strengthened our team spirit. It was truly inspiring to see everyone's motivation and commitment. Let's keep pushing those pedals to support sustainable mobility and a healthier planet. 🌍🌱 #Stadtradeln #CITYCYCLING #climateprotection #sustainability #strongtogether #teamwork

    • Kein Alt-Text für dieses Bild vorhanden
    • Kein Alt-Text für dieses Bild vorhanden
    • Kein Alt-Text für dieses Bild vorhanden
  • Unternehmensseite von Nuvisan anzeigen, Grafik

    14.663 Follower:innen

    It was such a great experience to participate in the Long Night of the Sciences and to meet all of the enthusiastic little scientists 👨🔬 👩🔬 It's a wrap! That was the Long Night of the Sciences 2024! 🤝 At our partner Campus Berlin-Buch GmbH in the Mensa on June 22, our visitors made fascinating slime with household materials. 💡🔬 Did you miss it? Browse through our photo gallery and make sure you continually follow us on LinkedIn so you won't miss out on our next fun experiment! #science #LNDW #experiments #NUVISAN

    • Kein Alt-Text für dieses Bild vorhanden
    • Kein Alt-Text für dieses Bild vorhanden
    • Kein Alt-Text für dieses Bild vorhanden
  • Unternehmensseite von Nuvisan anzeigen, Grafik

    14.663 Follower:innen

    🤝 ALS‘s Strategic Acquisition Drives Innovation and Science! As part of our commitment to growth and efficiency, effective April 1, the global leader in testing, ALS Limited, took full ownership of NUVISAN. This strategic acquisition extends our high-quality and personalized solutions to post-commercialization and multiple locations worldwide, presenting specific opportunities for our customers. 👀 Take a look at what our colleagues think about the acquisition and the exciting potential for the future -> https://lnkd.in/eB7uJQ8z #NUVISAN #ALS #acquisition #science #innovation #drugdiscovery #drugdevelopment

    • Kein Alt-Text für dieses Bild vorhanden
  • Unternehmensseite von Nuvisan anzeigen, Grafik

    14.663 Follower:innen

    👨🏻🏫 Join NUVISAN for a talk about human iPSCs on July 12 at the upcoming ISSCR Annual Meeting 2024!   Induced pluripotent stem cells (iPSCs) hold promise for regenerative medicine, drug screening and discovery, and advanced therapeutic medicinal products. At NUVISAN, we understand the intricacies of working with state-of-the-art methodologies to maximally leverage iPSCs in 2D and 3D model systems, and thrive in collaborative partnerships where we act as your scientific sparring partner to bring your research to the forefront.   Norman Liaw, the Head of the iPSC Platform and Senior Scientist at NUVISAN will share some insights on how we work to bring your bright idea, drug candidate or advanced project towards clinical translation whilst implementing human iPSCs in your drug discovery journey. Join us at the Exhibit Hall Theater H at the upcoming ISSCR 2024 in Hamburg, Germany on July 12, from 16:20 to 16:35.   🌈 Interested in having a more intimate chat with us and to pick up some free goodies? Don’t miss the chance to join Norman Liaw and our NUVISAN experts Claudia NoackSkadi Lau, Maike Marczenke, and Krzysztof Brzezinka at Booth 502. 💬 Schedule a meeting with us now: https://lnkd.in/eBGAuwPG or swing by at any time throughout the conference. We look forward to meeting you!   #StemCell #StemCellResearch #iPSC #Organoids #3DModeling #DiseaseModeling #HTS #Screening #Regeneration #RegenerativeMedicine #Science #ISSCR2024

    • Kein Alt-Text für dieses Bild vorhanden
  • Unternehmensseite von Nuvisan anzeigen, Grafik

    14.663 Follower:innen

    🚀 Our Science at NUVISAN: Cryo-Electron Microscopy(Cryo-EM) Here at NUVISAN, we combine our in-house protein science and cryo-electron microscopy (cryo-EM) expertise to deliver structures of your challenging pharmaceutical targets and enable structure-based drug discovery. In the world of cryo-EM, protein quality is key! Our team is specialized in preparing high quality GPCRs, ion channels, protein-nucleic acid complexes, and antibody-antigen complexes for cryo-EM. 👍 Fresh-is-best – Our same-site labs allow us to use freshly purified samples directly for grid preparation, thereby bypassing unnecessary freezing steps and significantly enhancing our success rates. In a recent project our Nuvisan protein production and cryo-EM experts successfully purified a Fab-bound A2A GPCR and determined the 3.4 Å cryo-EM structure of the GPCR complex in its inactive state. 💬 For more detailed insights on how we can support your projects connect with our cryo-EM team lead Alexander Ulrich or visit our webpage: https://lnkd.in/eC2rSKed #OurScience #cryoEM #proteinstructure #GPCR #membraneproteins #drugdiscovery #structuralbiology #proteintechnologies #ionchannels #theScienceCRO

    • Kein Alt-Text für dieses Bild vorhanden
  • Unternehmensseite von Nuvisan anzeigen, Grafik

    14.663 Follower:innen

    🚀 Proud and enthusiastic: We are a kununu Top Employer 2024! 🚀 We are delighted to announce that we have been recognized by kununu as one of the Top Employers 2024! 🎉 We owe this recognition above all to our amazing colleagues, whose commitment and passion make our company what it is. Your reviews and valuable feedback on kununu have helped us achieve this fantastic result. This feedback serves as a valuable basis for improvements and is the only way we can continue to grow. Reason for being a top employer:  🌟 Flexible working hours 🌟 Interesting tasks 🌟 Flat hierarchies 🌟 Team spirit A big thank you to our team, who contribute daily to our positive ratings as an employer. We are proud of this award and will continue to do our best to remain a first-class employer. Leave your feedback: https://lnkd.in/gZ9ePT6M  #topemployer #nuvisan #kununu #thankyou ------------------------------------------------------------------------------------ 🚀 Stolz und begeistert: Wir sind ein kununu Top Arbeitgeber 2024! 🚀   Wir freuen uns sehr, mitteilen zu können, dass wir von kununu als einer der Top Arbeitgeber 2024 ausgezeichnet wurden! 🎉 Diese Anerkennung verdanken wir vor allem unseren großartigen Kollegen:innen, deren Engagement und Leidenschaft unser Unternehmen zu dem machen, was es ist. Eure Bewertungen und das wertvolle Feedback auf kununu haben uns zu diesem fantastischen Ergebnis verholfen. Diese Rückmeldungen dienen als wertvolle Grundlage für Verbesserungen und nur so entwickeln wir uns weiter. Warum wir ein Top Arbeitgeber sind: 🌟 Flexible Arbeitszeiten 🌟 Interessante Aufgaben 🌟 Flache Hierarchien 🌟 Teamspirit   Ein großes Dankeschön an unser Team, das täglich dazu beiträgt, dass wir als Arbeitgeber so positiv bewertet werden. Wir sind stolz auf diese Auszeichnung und werden weiterhin unser Bestes geben ein erstklassiger Arbeitgeber zu bleiben. Hinterlasse gerne auch du dein Feedback: https://lnkd.in/gZ9ePT6M  #toparbeitgeber #nuvisan #kununu #dankeschön

    • Kein Alt-Text für dieses Bild vorhanden
  • Unternehmensseite von Nuvisan anzeigen, Grafik

    14.663 Follower:innen

    We are happy to be a member of Bundesverband Medizinischer Auftragsinstitute e.V. (BVMA)! Through our collaborative efforts, we strengthen clinical research and advance healthcare 🌐 #BVMA #ClinicalResearch #KlinischeForschung #CRO #Clinicaltrialsupply

    Unternehmensseite von BVMA - Bundesverband Medizinischer Auftragsinstitute e.V. anzeigen, Grafik

    1.618 Follower:innen

    Today we present one of our oldest member companies: The Science CRO - From Target to Patient Founded in Europe with more than 40 years of experience, Nuvisan is a fully integrated contract research and development, and manufacturing organization (CRO/CDMO) that offers unique, high-quality, and tailored integrated solutions along the drug discovery and development value chain. Keyfacts: 🔍 Focus on Science & Pharma Expertise 💡 Extensive Industry Experience 🤝“Science First“ & Customer Centric Focus 💊 One Partner along R&D Value Chain At our large study clinic in Germany, we conduct early clinical development trials such as first-in-human clinical trials and dose escalation studies with healthy subjects, along with pharmacokinetic studies on healthy subjects, special populations, and patients. NUVISAN's experts also provide high-quality consulting services in addition to practical clinical trial conduct and all related services. Our team can provide advice and support during the transition from preclinical to clinical development, including assistance with calculating the safe starting dose and preparing early clinical trial design. We are familiar with regulatory requirements and can provide support in all aspects of a clinical development program, including regulatory issues and biostatistical planning and evaluation. Nuvisan is pleased to offer the following portfolio of services: • Drug discovery & research - Discovery pharmacology - Discovery bioscience - Screening - Life science chemistry - Translation research - Digital life science - Toxicology – DMPK • Non-clinical studies • Pharmaceutical analysis • Topical formulation development • Chemical development with GMP manufacturing (3-10kg) • Bioanalytical labs • GMP manufacturing (up to 50Kg) • Clinical trial supplies • Phase 1 and 2 clinical studies and beyond Our services can be provided as stand-alone or integrated solutions and can be customized to your project.   We know how to discover, develop, and bring the next generation of medicines to market – all under one roof! To find out more, visit us: www.nuvisan.com   #BVMA #ClinicalResearch #KlinischeForschung #CRO #NUVISAN #Clinicaltrialsupply #integratedsolutions #wefeelresponsible https://lnkd.in/dmej6ecM

Ähnliche Seiten

Jobs durchsuchen